Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8605)
All Articles published online
|
Publishing Process of This Article
|
Feb 4, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Critical Care Medicine
ISSN
2220-3141
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leng YX, Yang SG, Song YH, Zhu X, Yao GQ. Ulinastatin for acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. World J Crit Care Med 2014; 3(1): 34-41 [PMID: 24834400 DOI: 10.5492/wjccm.v3.i1.34] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3141/full/v3/i1/34.htm |
| Number | Citing Articles |
| 1 |
Markus Huber-Lang, Kristina N. Ekdahl, Rebecca Wiegner, Karin Fromell, Bo Nilsson. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions. Seminars in Immunopathology 2018; 40(1): 87 doi: 10.1007/s00281-017-0646-9
|
| 2 |
Soo Jung Park, Sung Yong Park, Se Yoon Kang, Ji Ho Kim, Ji Yeong Heo, Ji Young Yoo. The effect of ulinastatin on acute kidney injury in patients undergoing off-pump cardiac bypass surgery. Journal of Cardiothoracic Surgery 2024; 19(1) doi: 10.1186/s13019-024-02562-9
|
| 3 |
Deduo Xu, Yi Shan, Qinghua Liu, Pei Liang, Xin Hao, Jinyuan Zhang, Ze Yu, Wenfang Li, Fei Gao, Xia Tao, Qin Gu, Yabin Ma, Wansheng Chen. Effectiveness of ulinastatin in critical care patients in real world: a retrospective multi-center study. Expert Review of Clinical Pharmacology 2024; 17(10): 985 doi: 10.1080/17512433.2024.2402433
|
| 4 |
Dadong Liu, Zongying Yu, Jiangtao Yin, Yikun Chen, Hao Zhang, Fan Xin, Haiyan Fu, Bing Wan. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients. Journal of Critical Care 2017; 39: 259 doi: 10.1016/j.jcrc.2016.12.013
|
| 5 |
Fu Wei, Si Yi Liu, Li Luo, Ni Na Gu, Yan Zeng, Xiao Ying Chen, Shan Xu, Dan Zhang. Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway. International Immunopharmacology 2017; 46: 220 doi: 10.1016/j.intimp.2017.03.007
|
| 6 |
M Uchida, T Abe, K Ono. THE EFFECTS OF ULINASTATIN IN MULTIPLE ORGAN FAILURE: A RETROSPECTIVE OBSERVATIONAL STUDY IN A SINGLE CENTER ICU. Intensive Care Medicine Experimental 2015; 3(Suppl 1): A878 doi: 10.1186/2197-425X-3-S1-A878
|
| 7 |
Zongyu Wang, Liyuan Tao, Yingying Yan, Xi Zhu. Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients. BMJ Open 2019; 9(3): e025523 doi: 10.1136/bmjopen-2018-025523
|
| 8 |
Linlin Ma, Chunsheng Li, Shuo Wang, Junyu Wang, Rui Shao, Chenchen Hang, Tao Wang. Ulinastatin ameliorates gastrointestinal injury sustained in a 2-hit porcine model of septic shock. The American Journal of Emergency Medicine 2016; 34(8): 1497 doi: 10.1016/j.ajem.2016.05.011
|
| 9 |
Jin Li, Meijun Li, Liren Li, Lin Ma, Ailin Cao, Aiping Wen, Wenge Chen, Lingling Li, Yan Liang, Jianxiong Deng. Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China. BMC Pharmacology and Toxicology 2022; 23(1) doi: 10.1186/s40360-022-00585-3
|
| 10 |
Li Zhang, Qiaohua Yan, Wei Zhang, Xiaoyuan Li, Xiu Zhang, Shijing Du, Xiaoping Hua, Juchun Lin, Gang Shu, Guangneng Peng, Zhenghuai Tan, Hualin Fu. Enhancement of the functionality of attenuating acute lung injury by a microemulsion formulation with volatile oil of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma encapsulated. Biomedicine & Pharmacotherapy 2022; 156: 113888 doi: 10.1016/j.biopha.2022.113888
|
| 11 |
Mingxia Ji, Tiejiang Chen, Baiming Wang, Mengyan Chen, Qianqian Ding, Lingchao Chen, Yuejuan Fang, Xiaofang Yu, Yanzhen Chen, Xiaohua Wang, Yiyue He, Yong Jiang. Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6012
|
| 12 |
Pragya Prasanna, Shweta Rathee, Arun Upadhyay, Sulakshana Sulakshana. Nanotherapeutics in the treatment of acute respiratory distress syndrome. Life Sciences 2021; 276: 119428 doi: 10.1016/j.lfs.2021.119428
|
| 13 |
Timothy D. Shaw, Daniel F. McAuley, Cecilia M. O’Kane. Emerging drugs for treating the acute respiratory distress syndrome. Expert Opinion on Emerging Drugs 2019; 24(1): 29 doi: 10.1080/14728214.2019.1591369
|
| 14 |
Qitong Lu, Zhiyong Liu, Wei He, Xin Chu. Protective effects of ulinastatin on rats with acute lung injury induced by lipopolysaccharide. Bioengineered 2024; 15(1) doi: 10.1080/21655979.2021.1987083
|
| 15 |
NirajKumar Keyal, Manish Nakarmi. Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit. CHRISMED Journal of Health and Research 2020; 7(1): 68 doi: 10.4103/cjhr.cjhr_45_19
|
| 16 |
Javier Checa, Josep M. Aran. Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. International Journal of Molecular Sciences 2020; 21(23): 9317 doi: 10.3390/ijms21239317
|
| 17 |
G. He, Q. Li, W. Li, Y. Ruan, X. Xiong, X. Song, F. Zeng. Effect of ulinastatin on interleukins and pulmonary function in bypass patients: a meta-analysis of randomized controlled trials. Herz 2020; 45(4): 335 doi: 10.1007/s00059-018-4732-0
|
| 18 |
Shi Zhang, Cuilin Chu, Zongsheng Wu, Feng Liu, Jianfeng Xie, Yi Yang, Haibo Qiu. IFIH1 Contributes to M1 Macrophage Polarization in ARDS. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.580838
|
| 19 |
Weiju Wang, Jie Weng, Lei Yu, Qiaobing Huang, Yong Jiang, Xiaohua Guo. Role of TLR4-p38 MAPK-Hsp27 signal pathway in LPS-induced pulmonary epithelial hyperpermeability. BMC Pulmonary Medicine 2018; 18(1) doi: 10.1186/s12890-018-0735-0
|
| 20 |
Hua-Song Zhou, Meng Li, Bing-Dong Sui, Lei Wei, Rui Hou, Wen-Sheng Chen, Qiang Li, Sheng-Hui Bi, Jin-Zhou Zhang, Ding-Hua Yi. Lipopolysaccharide impairs permeability of pulmonary microvascular endothelial cells via Connexin40. Microvascular Research 2018; 115: 58 doi: 10.1016/j.mvr.2017.08.008
|
| 21 |
Adam Linder, James A. Russell. An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor. Intensive Care Medicine 2014; 40(8): 1164 doi: 10.1007/s00134-014-3366-9
|
| 22 |
Han Liu, Xiu Yu, Sulan Yu, Junping Kou. Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. International Immunopharmacology 2015; 29(2): 937 doi: 10.1016/j.intimp.2015.10.010
|
| 23 |
Hong-Yuan Lin. The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy. Chinese Journal of Traumatology 2020; 23(4): 190 doi: 10.1016/j.cjtee.2020.06.002
|
| 24 |
Xiangyun Zhang, Zhaozhong Zhu, Weijie Jiao, Wei Liu, Fang Liu, Xi Zhu. Ulinastatin treatment for acute respiratory distress syndrome in China: a meta-analysis of randomized controlled trials. BMC Pulmonary Medicine 2019; 19(1) doi: 10.1186/s12890-019-0968-6
|
| 25 |
Musaddique Hussain, Shahzada Khurram Syed, Mobeen Fatima, Saira Shaukat, Malik Saadullah, Ali M Alqahtani, Taha Alqahtani, Talha Bin Emran, Ali H Alamri, Muhammad Qasim Barkat, Ximei Wu. Acute Respiratory Distress Syndrome and COVID-19: A Literature Review. Journal of Inflammation Research 2021; : 7225 doi: 10.2147/JIR.S334043
|
| 26 |
Katyayini Aribindi, Michelle Lim, Satyan Lakshminrusimha, Timothy Albertson. Investigational pharmacological agents for the treatment of ARDS. Expert Opinion on Investigational Drugs 2024; 33(3): 243 doi: 10.1080/13543784.2024.2315128
|
| 27 |
Leng Zhou, Haidan Lan, Qinghua Zhou, Xiao Jun Tang, Daxing Zhu, Jianming Yue, Bin Liu. Continuous infusion of high‐dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study. Thoracic Cancer 2016; 7(5): 581 doi: 10.1111/1759-7714.12371
|
| 28 |
Sarjana S. Atal, Shubham Atal. Ulinastatin – a newer potential therapeutic option for multiple organ dysfunction syndrome. Journal of Basic and Clinical Physiology and Pharmacology 2016; 27(2): 91 doi: 10.1515/jbcpp-2015-0003
|
| 29 |
Wenshuai Liu, Guozhong Pang, Shengyan Wang, Aiqin Sun. Protective effect of ulinastatin on severe pulmonary infection under immunosuppression and its molecular mechanism. Experimental and Therapeutic Medicine 2017; 14(4): 3583 doi: 10.3892/etm.2017.4993
|
| 30 |
Masatoshi Uchida, Toshikazu Abe, Kazuyuki Ono, Nanako Tamiya. Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU. Acute Medicine & Surgery 2018; 5(1): 90 doi: 10.1002/ams2.304
|